Corticoterapia prenatal y morbimortalidad del prematuro tardío: estudio prospectivo

Our finding suggests that the administration of antenatal corticosteroids to patients at risk of 34-36 weeks delivery could significantly reduce the cost and acute morbidity associated with late preterm birth.